Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be able to understand and agree to take part in the study, and be able to complete questionnaires and assessments accurately.
- You must be over 18 years old.
- You must have been diagnosed with postpartum depression, meaning your symptoms started within the first year after giving birth.
- You must score 14 or higher on a specific depression rating scale (called the HRSD17) at the start of the study (confirm with trial site).
Who may not be able to join:
- You cannot currently be pregnant.
- You cannot have a moderate or severe problem with substance use (such as alcohol or drugs), although tobacco use is an exception.
- You cannot currently be experiencing symptoms of psychosis (such as hallucinations or delusions).
- You cannot have a history of dementia or other significant memory or thinking problems.
- You cannot have active thoughts of suicide that require hospital care, or have made a suicide attempt in the past 3 months.
- You cannot have any medical reasons that would make receiving rTMS (a type of brain stimulation treatment) unsafe — for example, metal implants in the head or neck, a history of seizures, or any known brain injury (confirm with trial site).
- You cannot have any unstable or poorly controlled medical conditions.
- You cannot have experienced eclampsia (a serious condition involving seizures) during a previous pregnancy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 843-792-8274
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Determine feasibility and tolerability of accelerated iTBS for postpartum depression. The investigators hope to retain >80% of recruited patients (feasibility) and reach a full treatment dose of 120%rMT in >80% of enrolled women (tolerability).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.